Omeros (OMER) Return on Capital Employed Growth (1y) (2012 - 2026)
Omeros (OMER) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
31,429.00 |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
16,829.00 |
| 10 |
Omeros |
628.56 Mn |
493.24 Mn |
9.31 Mn |
5,151.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
5,151.00 |
| Dec 31, 2025 |
827.00 |
| Sep 30, 2025 |
-5,098.00 |
| Jun 30, 2025 |
-4,766.00 |
| Mar 31, 2025 |
-4,609.00 |
| Dec 31, 2024 |
-3,438.00 |
| Sep 30, 2024 |
-1,667.00 |
| Jun 30, 2024 |
-1,330.00 |
| Mar 31, 2024 |
-1,052.00 |
| Dec 31, 2023 |
-91.00 |
| Sep 30, 2023 |
47.00 |
| Jun 30, 2023 |
681.00 |
| Mar 31, 2023 |
789.00 |
| Dec 31, 2022 |
3,695.00 |
| Sep 30, 2022 |
13,376.00 |
| Jun 30, 2022 |
9,336.00 |
| Mar 31, 2022 |
5,796.00 |
| Dec 31, 2021 |
-1,297.00 |
| Sep 30, 2021 |
-8,031.00 |
| Jun 30, 2021 |
1,074.00 |
